Why a Buyout Deal May Not Be in the Cards for Acadia Post author:Sam Post published:November 27, 2017 Post category:BioPharma A look at why a potential buyout of Acadia might not be as likely as some have suggested. Source: BioSpace You Might Also Like 2 Fast-Rising Biotech Stocks With No Competition in Sight July 17, 2017 Kibow Biotech, Inc. (Buzz Of Bio Winner, 2014) Receives US Patent For Gout/Hyperuricemia Product Formulation Based On Modulation Of The Gut Microbiome With Probiotics And Prebiotics June 19, 2017 AbbVie Presents New Phase 2b Data on Upadacitinib in Atopic Dermatitis February 18, 2018
Kibow Biotech, Inc. (Buzz Of Bio Winner, 2014) Receives US Patent For Gout/Hyperuricemia Product Formulation Based On Modulation Of The Gut Microbiome With Probiotics And Prebiotics June 19, 2017